Movatterモバイル変換

[0]ホーム
URL:

Jump to content
WikipediaThe Free Encyclopedia
Search

A-423579

From Wikipedia, the free encyclopedia
A-423579
Stereo, Kekulé, skeletal formula of A-423,579 (({[(3R)-3-amino]}))
Stereo, Kekulé, skeletal formula of A-423,579 (({[(3R)-3-amino]}))
Names
Preferred IUPAC name
4′-{3-[(3R)-3-(Dimethylamino)pyrrolidin-1-yl]propoxy}-3′,5′-difluoro[1,1′-biphenyl]-4-carbonitrile
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
UNII
  • InChI=1S/C22H25F2N3O/c1-26(2)19-8-10-27(15-19)9-3-11-28-22-20(23)12-18(13-21(22)24)17-6-4-16(14-25)5-7-17/h4-7,12-13,19H,3,8-11,15H2,1-2H3/t19-/m1/s1 checkY
    Key: DJXFZKXYKKBTDR-LJQANCHMSA-N checkY
  • CN(C)C1CCN(CCCOC2=C(F)C=C(C=C2F)C2=CC=C(C=C2)C#N)C1
  • CN(C)C1CCN(CCCOc2c(F)cc(cc2F):c2ccc(cc2)C#N)C1
Properties
C22H25F2N3O
Molar mass385.4502 g/mol
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Chemical compound

A-423,579 is one of a range ofhistamine antagonists developed byAbbott Laboratories which are selective for theH3 subtype, and havestimulant andanorectic effects in animal studies making them potentially useful treatments forobesity. A-423,579 has improved characteristics over earlier drugs in the series with both high efficacy and low toxicity in studies on mice, and is currently in clinical development.[1][2]

References

[edit]
  1. ^Hancock AA, Diehl MS, Faghih R, Bush EN, Krueger KM, Krishna G, Miller TR, Wilcox DM, Nguyen P, Pratt JK, Cowart MD, Esbenshade TA, Jacobson PB (September 2004)."In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists".Basic & Clinical Pharmacology & Toxicology.95 (3):144–52.doi:10.1111/j.1742-7843.2004.950307.x.PMID 15447739.
  2. ^Hancock AA, Diehl MS, Fey TA, Bush EN, Faghih R, Miller TR, Krueger KM, Pratt JK, Cowart MD, Dickinson RW, Shapiro R, Knourek-Segel VE, Droz BA, McDowell CA, Krishna G, Brune ME, Esbenshade TA, Jacobson PB (April 2005). "Antiobesity evaluation of histamine H3 receptor (H3R) antagonist analogs of A-331440 with improved safety and efficacy".Inflammation Research.54: S27–9.doi:10.1007/s00011-004-0412-z.PMID 15928821.S2CID 22094031.
H1
Agonists
Antagonists
H2
Agonists
Antagonists
H3
Agonists
Antagonists
H4
Agonists
Antagonists


Stub icon

Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=A-423579&oldid=1152664091"
Categories:
Hidden categories:
[8]ページ先頭
©2009-2025 Movatter.jp